Valaciclovir Versus Acyclovir in the Treatment of First-Episode Genital Herpes Infection
| Autor: | Rick A. Barbarash, Timothy Rudolph, Robert Roth, Kenneth H. Fife, Barry Degregorio |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Microbiology (medical)
medicine.medical_specialty viruses medicine.medical_treatment Dermatology law.invention Double blind Randomized controlled trial law Medicine heterocyclic compounds Aciclovir First episode Chemotherapy business.industry Public Health Environmental and Occupational Health virus diseases biochemical phenomena metabolism and nutrition medicine.disease Surgery Valaciclovir Clinical trial Infectious Diseases business Genital herpes medicine.drug |
| Zdroj: | Sexually Transmitted Diseases. 24:481-486 |
| ISSN: | 0148-5717 |
| Popis: | Background and Objectives:Valaciclovir, the L-valine ester prodrug of acyclovir, is much better absorbed than acyclovir and produces acyclovir exposures three to five times those attainable with the parent drug.Goals:To determine whether the improved bioavailability of valaciclovir and a more conven |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|